Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.77 USD | -0.06% | +1.20% | +1.72% |
Jan. 21 | Pactiv Evergreen Reports Expiry of Waiting Period for Acquisition by Novolex | MT |
Jan. 10 | UBS Downgrades Pactiv Evergreen to Neutral From Buy, Raises Price Target to $18 From $16 | MT |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PTVE Stock
- News Pactiv Evergreen Inc.
- Apollo's Novolex to Buy Pactiv Evergreen for $18 a Share